1. Home
  2. HCTI vs COCP Comparison

HCTI vs COCP Comparison

Compare HCTI & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HCTI

Healthcare Triangle Inc.

HOLD

Current Price

$0.51

Market Cap

13.5M

Sector

Technology

ML Signal

HOLD

Logo Cocrystal Pharma Inc.

COCP

Cocrystal Pharma Inc.

HOLD

Current Price

$1.12

Market Cap

13.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCTI
COCP
Founded
2020
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.5M
13.5M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
HCTI
COCP
Price
$0.51
$1.12
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
686.7K
76.6K
Earning Date
11-13-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$12,942,000.00
N/A
Revenue This Year
$47.01
N/A
Revenue Next Year
$44.88
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.49
$0.90
52 Week High
$435.75
$2.67

Technical Indicators

Market Signals
Indicator
HCTI
COCP
Relative Strength Index (RSI) 19.05 60.50
Support Level $0.49 $0.91
Resistance Level $2.53 $1.01
Average True Range (ATR) 0.18 0.06
MACD -0.11 0.01
Stochastic Oscillator 1.56 85.71

Price Performance

Historical Comparison
HCTI
COCP

About HCTI Healthcare Triangle Inc.

Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their effort to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments: Software Services, Managed Services, and Support and Platform Services.

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

Share on Social Networks: